Genetic renal tumor

Genetic renal tumor is a broad classification term used by Orphanet (ORPHA:183595) to group kidney tumors that arise due to inherited genetic predispositions. This category encompasses a heterogeneous collection of renal neoplasms that occur in the context of hereditary cancer syndromes or familial predisposition, as opposed to sporadic (non-inherited) kidney cancers. Conditions grouped under this umbrella include, but are not limited to, hereditary renal cell carcinoma syndromes such as von Hippel-Lindau disease, hereditary papillary renal cell carcinoma (associated with MET gene mutations), Birt-Hogg-Dubé syndrome, hereditary leiomyomatosis and renal cell cancer (HLRCC), and familial Wilms tumor (nephroblastoma) in children. Tuberous sclerosis complex-associated renal tumors (angiomyolipomas and renal cell carcinoma) also fall within this grouping. The primary body system affected is the urinary system, specifically the kidneys, though many of the underlying hereditary syndromes have multisystem manifestations. Key clinical features vary by the specific genetic condition but commonly include renal masses (which may be bilateral or multifocal), hematuria (blood in the urine), flank pain, and in some cases hypertension. Many hereditary renal tumors present at a younger age than their sporadic counterparts and may be detected incidentally on imaging or through surveillance programs in known at-risk families. Some syndromes carry additional features such as skin lesions, pulmonary cysts, pheochromocytomas, or retinal angiomas. Treatment depends on the specific tumor type and underlying genetic syndrome. Surgical approaches, including nephron-sparing surgery (partial nephrectomy), are often preferred to preserve kidney function, especially given the risk of bilateral or recurrent tumors. Targeted therapies such as mTOR inhibitors (e.g., everolimus in tuberous sclerosis) or VEGF pathway inhibitors (e.g., in VHL-associated renal cell carcinoma) may be used. Active surveillance is an important strategy for small tumors. Genetic counseling and cascade testing of family members are essential components of management for all hereditary renal tumor syndromes.

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Common questions about Genetic renal tumor